Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis

[1]  E. Masliah,et al.  A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.

[2]  J. Hay,et al.  α-Synuclein Delays Endoplasmic Reticulum (ER)-to-Golgi Transport in Mammalian Cells by Antagonizing ER/Golgi SNAREs , 2010, Molecular biology of the cell.

[3]  Charles Boone,et al.  Trans-Golgi network and endosome dynamics connect ceramide homeostasis with regulation of the unfolded protein response and TOR signaling in yeast. , 2008, Molecular biology of the cell.

[4]  T. Iwatsubo,et al.  A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.

[5]  J. Winderickx,et al.  Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. , 2008, Biochimica et biophysica acta.

[6]  E. Wanker,et al.  Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. , 2008, Journal of molecular biology.

[7]  S. Lindquist,et al.  The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.

[8]  J. Trojanowski,et al.  Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. , 2007, Molecular biology of the cell.

[9]  S. Munro,et al.  An elaborate classification of SNARE proteins sheds light on the conservation of the eukaryotic endomembrane system. , 2007, Molecular biology of the cell.

[10]  Peter T Lansbury,et al.  Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. , 2007, Journal of molecular biology.

[11]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[12]  Yves Barral,et al.  Bioinformatic and Comparative Localization of Rab Proteins Reveals Functional Insights into the Uncharacterized GTPases Ypt10p and Ypt11p , 2006, Molecular and Cellular Biology.

[13]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[14]  W. Woods,et al.  A Novel Mechanism of Interaction between α-Synuclein and Biological Membranes , 2006 .

[15]  W. Webb,et al.  Quantification of α-Synuclein Binding to Lipid Vesicles Using Fluorescence Correlation Spectroscopy , 2006 .

[16]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[17]  N. Hattori,et al.  A Combinatorial Code for the Interaction of α-Synuclein with Membranes* , 2005, Journal of Biological Chemistry.

[18]  Paul H. Axelsen,et al.  The E46K Mutation in α-Synuclein Increases Amyloid Fibril Formation* , 2005, Journal of Biological Chemistry.

[19]  H. Tanila,et al.  Role of α-Synuclein in Presynaptic Dopamine Recruitment , 2004, The Journal of Neuroscience.

[20]  R. Tsien,et al.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.

[21]  Giuseppe Battaglia,et al.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[23]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .

[24]  A. Neiman,et al.  Positive and negative regulation of a SNARE protein by control of intracellular localization. , 2004, Molecular biology of the cell.

[25]  T. Gómez-Isla,et al.  Abnormal α‐Synuclein Interactions with Rab Proteins in α‐Synuclein A30P Transgenic Mice , 2004 .

[26]  T. Gómez-Isla,et al.  Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. , 2004, Journal of neuropathology and experimental neurology.

[27]  Gary D Bader,et al.  Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.

[28]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[29]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[30]  Susan Lindquist,et al.  Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein , 2003, Science.

[31]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[32]  A. Nakano,et al.  Cdc50p, a conserved endosomal membrane protein, controls polarized growth in Saccharomyces cerevisiae. , 2003, Molecular biology of the cell.

[33]  D. Gallwitz,et al.  Biochemical and Genetic Evidence for the Involvement of Yeast Ypt6-GTPase in Protein Retrieval to Different Golgi Compartments* , 2003, The Journal of Biological Chemistry.

[34]  H. Pelham,et al.  Vps51p Links the VFT Complex to the SNARE Tlg1p* , 2002, The Journal of Biological Chemistry.

[35]  J. Schmitzová,et al.  Significance of GTP Hydrolysis in Ypt1p-regulated Endoplasmic Reticulum to Golgi Transport Revealed by the Analysis of Two Novel Ypt1-GAPs* , 2002, The Journal of Biological Chemistry.

[36]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[37]  Vladimir N Uversky,et al.  Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.

[38]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Bruce A. Yankner,et al.  Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.

[40]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[41]  H. Pelham,et al.  An effector of Ypt6p binds the SNARE Tlg1p and mediates selective fusion of vesicles with late Golgi membranes , 2001, The EMBO journal.

[42]  N. Chaffey.  Red fluorescent protein , 2001 .

[43]  J. Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[44]  P. Novick,et al.  A snc1 endocytosis mutant: phenotypic analysis and suppression by overproduction of dihydrosphingosine phosphate lyase. , 2000, Molecular biology of the cell.

[45]  B. Levi,et al.  The sodium/proton exchanger Nhx1p is required for endosomal protein trafficking in the yeast Saccharomyces cerevisiae. , 2000, Molecular biology of the cell.

[46]  R. Perrin,et al.  Interaction of Human α-Synuclein and Parkinson's Disease Variants with Phospholipids , 2000, The Journal of Biological Chemistry.

[47]  S. Ha,et al.  Sorting of Yeast Membrane Proteins into an Endosome-to-Golgi Pathway Involves Direct Interaction of Their Cytosolic Domains with Vps35p , 2000, The Journal of cell biology.

[48]  H. Pelham,et al.  Ric1p and Rgp1p form a complex that catalyses nucleotide exchange on Ypt6p , 2000, The EMBO journal.

[49]  V. Kushnirov.  Rapid and reliable protein extraction from yeast , 2000, Yeast.

[50]  Howard Riezman,et al.  The F-Box Protein Rcy1p Is Involved in Endocytic Membrane Traffic and Recycling Out of an Early Endosome in Saccharomyces cerevisiae , 2000, The Journal of cell biology.

[51]  J. Trojanowski,et al.  A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease , 2000, Journal of neuroscience research.

[52]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[53]  D. Gallwitz,et al.  Two New Members of a Family of Ypt/Rab GTPase Activating Proteins , 1999, The Journal of Biological Chemistry.

[54]  S. Emr,et al.  Cytoplasm to vacuole trafficking of aminopeptidase I requires a t‐SNARE–Sec1p complex composed of Tlg2p and Vps45p , 1999, The EMBO journal.

[55]  M. Citron,et al.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.

[56]  J. Trojanowski,et al.  Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein , 1999, Neuroscience Letters.

[57]  W. Hong,et al.  A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae. , 1999, Molecular biology of the cell.

[58]  S. Munro,et al.  The GRIP domain – a novel Golgi-targeting domain found in several coiled-coil proteins , 1999, Current Biology.

[59]  J. Trojanowski,et al.  Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro * , 1999, The Journal of Biological Chemistry.

[60]  P. Novick,et al.  The exocyst is an effector for Sec4p, targeting secretory vesicles to sites of exocytosis , 1999, The EMBO journal.

[61]  D. Gallwitz,et al.  Primary structure and biochemical characterization of yeast GTPase-activating proteins with substrate preference for the transport GTPase Ypt7p. , 1999, European journal of biochemistry.

[62]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[63]  Z. Xie,et al.  Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Goedert,et al.  Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation* , 1998, The Journal of Biological Chemistry.

[65]  A. Jonas,et al.  Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.

[66]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[67]  J. Boeke,et al.  Designer deletion strains derived from Saccharomyces cerevisiae S288C: A useful set of strains and plasmids for PCR‐mediated gene disruption and other applications , 1998, Yeast.

[68]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[69]  Anne Robbins,et al.  Identification of proteins that interact with a protein of interest: Applications of the yeast two-hybrid system , 1997, Molecular and Cellular Biochemistry.

[70]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[71]  M. Fang,et al.  Kes1p shares homology with human oxysterol binding protein and participates in a novel regulatory pathway for yeast Golgi‐derived transport vesicle biogenesis. , 1996, The EMBO journal.

[72]  D. Robinson,et al.  Two GTPase isoforms, Ypt31p and Ypt32p, are essential for Golgi function in yeast. , 1996, The EMBO journal.

[73]  D. Gallwitz,et al.  Isolation and characterization of SYS genes from yeast, multicopy suppressors of the functional loss of the transport GTPase Ypt6p. , 1996, Journal of cell science.

[74]  G. Daum,et al.  Isolation and biochemical characterization of organelles from the yeast, Saccharomyces cerevisiae , 1995, Yeast.

[75]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[76]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[77]  P. Philippsen,et al.  Role of three rab5-like GTPases, Ypt51p, Ypt52p, and Ypt53p, in the endocytic and vacuolar protein sorting pathways of yeast , 1994, The Journal of cell biology.

[78]  H. Riezman,et al.  Involvement of Ypt7p, a small GTPase, in traffic from late endosome to the vacuole in yeast. , 1993, Journal of cell science.

[79]  P. Novick,et al.  Homologs of the synaptobrevin/VAMP family of synaptic vesicle proteins function on the late secretory pathway in S. cerevisiae , 1993, Cell.

[80]  S. Pfeffer,et al.  Rab GDI: a solubilizing and recycling factor for rab9 protein. , 1993, Molecular biology of the cell.

[81]  D. Gallwitz,et al.  A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family , 1993, Nature.

[82]  Ludger Hengst,et al.  Endocytosis in yeast: Evidence for the involvement of a small GTP-binding protein (Ypt7p) , 1992, Cell.

[83]  G. Anantharamaiah,et al.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.

[84]  M. Goebl,et al.  Mutations in the CDP-choline pathway for phospholipid biosynthesis bypass the requirement for an essential phospholipid transfer protein , 1991, Cell.

[85]  F. Foury.  The 31-kDa polypeptide is an essential subunit of the vacuolar ATPase in Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.

[86]  A. Cleves,et al.  An essential role for a phospholipid transfer protein in yeast Golgi function , 1990, Nature.

[87]  A. Cleves,et al.  Cloning and characterization of Kluyveromyces lactis SEC14, a gene whose product stimulates Golgi secretory function in Saccharomyces cerevisiae , 1990, Journal of bacteriology.

[88]  T. Tomita,et al.  Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study , 1977, Acta Neuropathologica.

[89]  L. Forno,et al.  Ultrastructure of Lewy bodies in the stellate ganglion , 1976, Acta Neuropathologica.

[90]  V. Tennyson,et al.  Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .

[91]  H. Brown,et al.  Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. , 2007, Methods in enzymology.

[92]  H. Brown.  Lipidomics and bioactive lipids : mass-spectrometry-based lipid analysis , 2007 .

[93]  M. Yokochi,et al.  An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism , 2004, Acta Neuropathologica.

[94]  A. Nakano,et al.  Cdc 50 p , a Conserved Endosomal Membrane Protein , Controls Polarized Growth in Saccharomyces cerevisiae , 2003 .

[95]  M. Citron,et al.  a-Synuclein Fibrillogenesis Is Nucleation-dependent IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON 9 S DISEASE , 1999 .

[96]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.